SPRY - ARS Pharmaceuticals, Inc.
NEXT EARNINGS:
Mar 19, 2026
(in 22 days)
EPS Est: $-0.42
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$31.00
DETAILS
HIGH:
$32.00
LOW:
$30.00
MEDIAN:
$31.00
CONSENSUS:
$31.00
UPSIDE:
239.17%
Market Cap:
903.48M
Volume:
665,729
Avg Volume:
1,611,266
52 Week Range:
6.66-18.9
Sector:
Healthcare
Industry:
Biotechnology
Beta:
0.74
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
155
IPO Date:
2020-12-04
EPS (TTM):
0.08
P/E Ratio:
127.87
Revenue (TTM):
89.15M
Total Assets:
351.15M
Total Debt:
42,000
Cash & Equiv:
50.82M
Rev Growth (5Y):
49.5%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-0.9%
Debt/Equity:
0.00
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-10 | $-0.52 | $-0.45 | -15.6% | $32.5M | $25.6M | +27.0% |
| 2025-08-13 | $-0.46 | $-0.41 | -12.2% | $15.7M | $27.7M | -43.2% |
| 2025-05-14 | $-0.35 | $-0.35 | 0.0% | $8.0M | $14.7M | -45.8% |
| 2025-03-20 | $0.52 | $-0.04 | +1400.0% | $86.6M | $12.8M | +574.4% |
| 2024-11-13 | $-0.20 | $-0.18 | -11.1% | $2.1M | $17.1M | -87.9% |
| 2024-08-06 | $-0.13 | $-0.12 | -8.3% | $500000 | $1.0M | -50.0% |
| 2024-05-09 | $-0.11 | $-0.11 | 0.0% | — | — | — |
| 2024-03-21 | $-0.07 | $-0.14 | +50.0% | $30000 | — | — |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|
| Revenue | 89.15M | 30,000 | 1.32M | 5.51M | 17.84M | 0 | 0 |
| Net Income | 8.00M | (54.37M) | (34.68M) | (20.24M) | (1.06M) | (23.97M) | (17.58M) |
| EPS | 0.08 | -0.57 | -0.87 | -0.70 | -0.03 | -0.72 | -0.53 |
| Total Assets | 351.15M | 233.19M | 281.44M | 61.45M | 26.41M | 15.65M | 27.55M |
| Total Debt | 42,000 | 274,000 | 481,000 | 9.03M | 10.02M | 15.62M | 7.73M |
| Cash & Equivalents | 50.82M | 70.97M | 210.52M | 60.06M | 24.52M | 9.98M | 20.16M |
| Operating Cash Flow | 13.55M | (59.27M) | (40.08M) | (17.56M) | 9.07M | (18.90M) | (16.88M) |
| Free Cash Flow | 12.98M | (59.44M) | (40.28M) | (17.62M) | 8.15M | (18.99M) | (17.32M) |
| FCF per Share | 0.13 | -0.62 | -1.01 | -0.61 | 0.23 | -0.57 | -0.52 |
| Book Value | 256.80M | 230.76M | 272.89M | (31.27M) | (14.05M) | (5.60M) | 18.20M |
| Cash & ST Investments | 314.02M | 228.36M | 274.38M | 60.06M | 24.52M | 9.98M | 20.16M |
| ROC Equity | 0.03 | -0.24 | -0.13 | N/A | N/A | N/A | -0.97 |